Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer

MLA

Kimihiro, Yamashita, et al. “Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer.” Anticancer Research, vol. 36, no. 7, Apr. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........09851723d32c57299814103b7a55e6f4&authtype=sso&custid=ns315887.

APA

Kimihiro, Y., Hiroshi, H., Mitsugu, F., Masayasu, N., Tomoko, T., Akira, A., Satoshi, S., Takashi, K., & Yoshihiro, K. (2016). Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer. Anticancer Research, 36(7).

Chicago

Kimihiro, Yamashita, Hasegawa Hiroshi, Fujita Mitsugu, Nishi Masayasu, Tanaka Tomoko, Arimoto Akira, Suzuki Satoshi, Kamigaki Takashi, and Kakeji Yoshihiro. 2016. “Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer.” Anticancer Research 36 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........09851723d32c57299814103b7a55e6f4&authtype=sso&custid=ns315887.